Inventor · disambiguated record
Jolie Anne Bastian
Also filed as: BASTIAN JOLIE A · BASTIAN JOLIE ANNE
30 granted patents·2 pending applications·172 citations·filing 1997–2025
96Inventor score
Top patents by PatentIndex Score
32 records- 0197US10654866B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2019·Granted May 19, 2020·15 cites·19 claims
- 0296US11117902B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2020·Granted Sep 14, 2021·6 cites·16 claims
- 0395US11634426B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2021·Granted Apr 25, 2023·3 cites·20 claims
- 0490US6177440B1Substituted tricyclicsLILLY CO ELI·Filed 1998·Granted Jan 23, 2001·60 cites·32 claims
- 0587US9872853B22,3-dihydro-1H-indole compoundsLILLY CO ELI·Filed 2017·Granted Jan 23, 2018·4 cites·8 claims
- 0687US6713645B1Substituted tricyclicsLILLY CO ELI·Filed 2000·Granted Mar 30, 2004·21 cites·2 claims
- 0785US10759786B21-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancerLILLY CO ELI·Filed 2017·Granted Sep 1, 2020·3 cites·5 claims
- 0885US7087635B23-substituted oxindole β3 agonistsLILLY CO ELI·Filed 2005·Granted Aug 8, 2006·10 cites·4 claims
- 0982US11993608B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2023·Granted May 28, 2024·0 cites·12 claims
- 1081US6911463B23-substituted oxindole β-3 agonistsLILLY CO ELI·Filed 2002·Granted Jun 28, 2005·11 cites·7 claims
- 1174US6025382AAntithrombotic diaminesLILLY CO ELI·Filed 1997·Granted Feb 15, 2000·15 cites·21 claims
- 1272US7071208B2β3 Adrenergic agonistsLILLY CO ELI·Filed 2002·Granted Jul 4, 2006·4 cites·5 claims
- 1367US12351591B2KRas inhibitorsLILLY CO ELI·Filed 2023·Granted Jul 8, 2025·0 cites·33 claims
- 1464US10323019B2Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsLILLY CO ELI·Filed 2017·Granted Jun 18, 2019·0 cites·18 claims
- 1564US6541499B1Antithrombotic agentsLILLY CO ELI·Filed 1998·Granted Apr 1, 2003·11 cites·10 claims
- 1663US2025289830A1Kras inhibitorsLILLY CO ELI·Filed 2025·Application pending·0 cites
- 1760US10344018B2Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsLILLY CO ELI·Filed 2019·Granted Jul 9, 2019·0 cites·9 claims
- 1860US7297706B2Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disordersLILLY CO ELI·Filed 2006·Granted Nov 20, 2007·0 cites·13 claims
- 1960US7253181B2β3 adrenergic agonistsLILLY CO ELI·Filed 2006·Granted Aug 7, 2007·0 cites·6 claims
- 2060US2024368193A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2159US7265127B2β3 adrenergic agonistsLILLY CO ELI·Filed 2006·Granted Sep 4, 2007·0 cites·6 claims
- 2259US7241772B2β3 adrenergic agonistsLILLY CO ELI·Filed 2006·Granted Jul 10, 2007·0 cites·4 claims
- 2356US6620837B1Antithrombotic agentsLILLY CO ELI·Filed 2000·Granted Sep 16, 2003·1 cites·16 claims
- 2454US8445493B2Tetrasubstituted pyridazines hedgehog pathway antagonistsBASTIAN JOLIE ANNE·Filed 2009·Granted May 21, 2013·0 cites·9 claims
- 2551US8404687B2Disubstituted phthalazine hedgehog pathway antagonistsBASTIAN JOLIE ANNE·Filed 2009·Granted Mar 26, 2013·0 cites·13 claims
- 2650US7078415B2Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disordersLILLY CO ELI·Filed 2002·Granted Jul 18, 2006·0 cites·16 claims
- 2748US8507490B2Tetrasubstituted pyridazine hedgehog pathway antagonistsBASTIAN JOLIE ANNE·Filed 2009·Granted Aug 13, 2013·0 cites·15 claims
- 2848US6265416B1Antithrombotic agentsLILLY CO ELI·Filed 1999·Granted Jul 24, 2001·6 cites·9 claims
- 2943US7652015B2Kinase inhibitorsLILLY CO ELI·Filed 2006·Granted Jan 26, 2010·0 cites·9 claims
- 3043US7205407B23-Substituted oxindole β3 agonistsLILLY CO ELI·Filed 2002·Granted Apr 17, 2007·0 cites·6 claims
- 3141US7208505B2β3 adrenergic agonistsLILLY CO ELI·Filed 2002·Granted Apr 24, 2007·0 cites·7 claims
- 3236US6251921B1Antithrombotic diaminesLILLY CO ELI·Filed 1999·Granted Jun 26, 2001·2 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Jolie Anne Bastian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →